While defects in MMR proteins lead to TMZ resistance and tumorigenesis, MMR deficiency has also been associated with better response to ICBs at least in NSCLC (207) and colorectal carcinoma (208). This evidence concerns the gene MRC1 and hyperinsulinemic hypoglycemia, familial, 4.